Read articles from Global

January 22, 2025 by whyy.org

FDA regulation of nicotine pouches can help prevent youth use, say Rutgers researchers

Nicotine pouches, like the Zyn brand, are gaining traction in the U.S. market as a smokeless alternative to traditional tobacco products. Recently, the U.S. Food and Drug Administration (FDA) authorized Zyn as a less harmful option compared to cigarettes and other smokeless tobacco products. While researchers see potential for harm reduction among smokers, they emphasize the need for stricter marketing oversight to prevent youth usage. Currently, nicotine pouch use among teens is low, with fewer than 2% of middle and high school students reporting use in the past year, according to the 2024 National Youth Tobacco Survey.

January 22, 2025 by daily-pouch.com

The Strange Rise of Apps That “Help” People Stop Using Nicotine

Startups need product-market fit, solving real problems. Anti-nicotine apps like Jones, despite good marketing, face challenges. They focus on quitting vaping and pouches, which cater to a small market. Investors' $5 million bet on Jones may struggle due to the shrinking vaping trend. Critically, these apps may not address significant issues, unlike stop smoking apps. While hoping for their success, the effectiveness and ethical concerns of anti-nicotine apps remain questionable, as they target a less urgent problem compared to smoking cessation.

January 22, 2025 by medicalxpress.com

Study reveals diverse perceptions of vaping dangers among students

To understand factors that led to the escalation, researchers at the University of Alabama at Birmingham studied how college students perceived the health risks of e-cigarettes compared to traditional cigarettes. The results showed the perception of the potential harm of e-cigarettes varied based on factors like sex, vaping status, and field of study/work. "We found that non-users and females were less likely to believe that e-cigarettes were less harmful than traditional cigarettes," said M.J. Ruzmyn Vilcassim, Ph.D., assistant professor in the UAB School of Public Health and lead author. "Conversely, male vapers and users of pod-type devices were more likely to view the devices as less harmful."

January 21, 2025 by thefirebreak.org

Should America be Leaving the WHO?

In 2018, discussions were held on reforming the International Agency for Research on Cancer (IARC) within the WHO. Suggestions to stay in and reform IARC were made based on concerns regarding activist influences and collaborations with US tort lawyers. The US government intervened in IARC decisions, delaying publications and influencing reports. Despite criticisms of the WHO and its political agenda, leaving the organization may lead to limited influence in global health decisions, especially in combating industry relations. The decision to exit the WHO, made by the US in 2020, may result in diminished influence over global health policies and WHO's strategies, including denormalizing industry relations.

January 21, 2025 by jamanetwork.com

Prevalence of Popular Smoking Cessation Aids in England and Associations With Quit Success

This survey study including 25 094 smokers aged at least 16 years found that e-cigarettes were both the most commonly used cessation aid (used in 40.2% of quit attempts in 2023-2024) and associated with the highest odds of successful cessation. By contrast, other aids found to be associated with increased odds of success in quitting smoking were used in less than 5% of quit attempts.

January 20, 2025 by clivebates.com

Fixing the broken and lawless American tobacco and nicotine market

Fixing the broken tobacco and nicotine market requires a radical overhaul of the authorisation process for smoke-free products, lowering barriers to entry and pushing back a giant illicit market. This report provides analysis and a framework to support the reform of federal tobacco and nicotine market regulation, one of the most chaotic and conspicuous failures of the federal government and Food and Drug Administration.

January 20, 2025 by thesun.co.uk

System could not access the page, the title must be completed manually

System could not access the page, the text article must be completed manually

January 17, 2025 by gfn.tv

GFN News #130 | THERAPEUTIC NICOTINE EXPLAINED Pt.1 | Featuring Michael Kariuki

Public perceptions of nicotine have long been marred by its association with harmful constituents of tobacco smoke, despite the substantial evidence showing that nicotine is not responsible for the many non-communicable diseases caused by tobacco smoking. Nicotine, safely administered, has long been accepted by governments and health authorities, including the WHO, as a valuable tool to aid smoking cessation in the form of nicotine replacement therapy. Joining us today is Michael Kariuki, a consultant pediatrician and epidemiologist from Kenya, to discuss the therapeutic applications of nicotine and the vital role of safer nicotine products in aiding smoking cessation.

January 17, 2025 by telegraph.co.uk

The risks of vaping and how to quit

To break a vaping addiction, strategies include tapering nicotine strength gradually, identifying triggers and seeking therapy, setting boundaries, using distractions like sweets, trying apps or text support interventions for quitting, and considering drug therapies like varenicline and cytisine. Progress can be hindered by triggers and a tendency to increase vaping frequency when reducing nicotine. Support from a buddy can aid in setting boundaries. It's crucial not to return to smoking cigarettes to avoid the unique risks they pose. Pharmacological therapies are available, but not yet licensed for vaping cessation in the UK, except for Nicorette’s QuickMist mouth spray.

January 17, 2025 by usatoday.com

FDA authorizes Zyn nicotine pouches, cites lower risk than cigarettes

The FDA authorized Zyn nicotine pouches, deeming them lower risk than cigarettes due to reduced harmful constituents. This decision contrasts with the proposed rule to slash nicotine levels in cigarettes. Critics, such as the Campaign for Tobacco-Free Kids, denounce the move, citing concerns about youth appeal and potential harm. Juul Labs settled with six states over false marketing claims targeting minors, while Philip Morris invests in Zyn production. Although the FDA warns against tobacco use, Zyn pouches offer a non-tobacco alternative. Nicotine in youth can harm brain functions, as stated by the CDC.

RELATED VIDEOS

video youtube thumbnail

28 September 2026

76% of the Global Vape Market Is Illicit?!

video youtube thumbnail

19 November 2026

CRITICAL MASS | Global Safer Nicotine Use Reaches 200 Million

video youtube thumbnail

10 July 2026

Europe’s New Prohibition: The End of Safer Nicotine? | Dr Konstantinos Farsalinos

video youtube thumbnail

24 August 2026

Nicotine Pouches in Scandinavia - How Sales Have Changed From 2018 to 2025?

video youtube thumbnail

23 August 2024

What are the key insights from Global Forum on Nicotine? | #GFNVoices24

video youtube thumbnail

13 May 2026

THR Global - The Building Block Secret to Changing Tobacco Policy

video youtube thumbnail

27 May 2024

What makes GFN24 a truly GLOBAL event?

video youtube thumbnail

22 December 2025

Global Forum on Nicotine 2025 Closing remarks by David Sweanor